Company Description
Sintx Technologies, Inc., an advanced ceramics and biomaterials company, engages in the research, development, manufacturing, and commercialization of silicon nitride biomaterials, composites, devices, and related technologies for medical and other applications in the United States.
The company offers monolithic solid silicon nitride; solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyether ether ketone, and Polyether Ether Ketone (PEE).
It also provides insulators for Tier 1 aerospace suppliers; SiNAPTIC® Foot & Ankle Osteotomy Wedge System for reconstructive surgery; OEM manufacturing of spinal implants; and SiNERGY™ technology platform for bio composite and 3D printing applications.
The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.
| Country | United States |
| Founded | 1996 |
| IPO Date | Feb 13, 2014 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 32 |
| CEO | Eric Olson |
Contact Details
Address: 1885 West 2100 South Salt Lake City, Utah 84119 United States | |
| Phone | 801 839 3500 |
| Website | sintx.com |
Stock Details
| Ticker Symbol | SINT |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001269026 |
| CUSIP Number | 829392703 |
| ISIN Number | US8293927039 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Eric K. Olson | Chief Executive Officer and Chairman of the Board |
| Kevin Trask | Chief Financial Officer |
| Gregg Richard Honigblum | Chief Investment Officer and Director |
| Ryan Elmore | President |
| Kevin J. Ontiveros Esq. | Chief Legal Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 5, 2026 | 8-K | Current Report |
| Nov 5, 2026 | 10-Q | Quarterly Report |
| Oct 30, 2026 | DEF 14A | Other definitive proxy statements |
| Oct 9, 2026 | 8-K | Current Report |
| Oct 1, 2026 | 8-K | Current Report |
| Aug 18, 2026 | EFFECT | Notice of Effectiveness |
| Aug 13, 2026 | SCHEDULE 13G | Filing |
| Aug 13, 2026 | 8-K | Current Report |
| Aug 13, 2026 | S-3 | Registration statement under Securities Act of 1933 |
| Aug 11, 2026 | 8-K | Current Report |